OAK BROOK, Ill. – May 23, 2011 – Researchers from China report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe ...

The reported proportion of 34% of patients with advanced-stage HCC may be misleading, as 41% had extrahepatic disease and 19% had portal vein invasion. Official guidelines 4-6 concur that ...

A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I.

Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

Please provide your email address to receive an email when new articles are posted on . Transarterial chemoembolization plus vitamin K prolonged progression-free survival compared with TACE alone (262 ...

Leesburg, VA, July 31, 2019--Aspirin therapy is associated with both improved liver function test results and survival after transarterial embolization (TAE) for hepatocellular carcinoma (HCC), ...

Researchers report that in patients with peptic ulcer bleeding in whom endoscopy failed to control the bleeding, transarterial embolization is a safe procedure which reduces the need for surgery ...